IDEAYA Biosciences Inc header image

IDEAYA Biosciences Inc

IDYA

Equity

ISIN null / Valor 47686107

NASDAQ (2026-08-07)
USD 37.02+2.15%

IDEAYA Biosciences Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

IDEAYA Biosciences Inc. is a clinical-stage precision medicine oncology company based in South San Francisco, California. The company focuses on the discovery and development of targeted therapeutics for cancer patients, utilizing molecular diagnostics to select patient populations. IDEAYA's primary area of expertise is in synthetic lethality, a novel class of precision medicine targets. The company integrates target and biomarker discovery with the development of small molecule and protein degrader therapeutics, spanning from early discovery stages through clinical development. IDEAYA aims to address unmet needs in cancer treatment by advancing therapeutics that have the potential to be first-in-class or best-in-class.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

65.2%1Y
71.9%3Y
59.8%5Y

Performance

48.6%1Y
49.5%3Y
58.7%5Y

Volatility

Market cap

3572 M

Market cap (USD)

Daily traded volume (Shares)

602,342

Daily traded volume (Shares)

1 day high/low

25.07 / 24.31

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Wesley Jefferson Yap
UK, 04 Nov 2025
star star star star star
What an increase, even though it is temporary

EQUITIES OF THE SAME SECTOR

Kontron AG
Kontron AG Kontron AG Valor: 10395864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.97%EUR 21.78
UBISOFT Entertainment
UBISOFT Entertainment UBISOFT Entertainment Valor: 491199
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.43%EUR 5.38
Equasens
Equasens Equasens Valor: 29127567
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%EUR 34.00
Vetoquinol SA
Vetoquinol SA Vetoquinol SA Valor: 1393361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%EUR 72.60
MERSEN
MERSEN MERSEN Valor: 504642
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.04%EUR 40.68
Camtek Ltd
Camtek Ltd Camtek Ltd Valor: 1072263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.80%USD 155.35
CANCOM SE
CANCOM SE CANCOM SE Valor: 883557
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.43%EUR 24.90
Elmos Semiconductor SE
Elmos Semiconductor SE Elmos Semiconductor SE Valor: 810140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%EUR 146.00
Sinch AB
Sinch AB Sinch AB Valor: 112110749
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.15%SEK 44.19
Alphabet Inc
Alphabet Inc Alphabet Inc Valor: 29798540
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%USD 354.30